Phase II trial of pegylated liposomal doxorubicin as consolidation chemotherapy in patients with stage III or IV ovarian or primary peritoneil carcinoma.

被引：0
|
作者：
Disilvestro, PA
Fisher, M
Pearl, M
Valea, F
Buhl, A
Chalas, E
机构：
[1] Women & Infants Hosp Rhode Isl, Providence, RI USA
[2] SUNY Stony Brook, Stony Brook, NY 11794 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5112
引用
收藏
页码：477S / 477S
页数：1
相关论文
共 50 条
  • [21] Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
    Ferrero, J. -M.
    Weber, B.
    Geay, J. -F.
    Lepille, D.
    Orfeuvre, H.
    Combe, M.
    Mayer, F.
    Leduc, B.
    Bourgeois, H.
    Paraiso, D.
    Pujade-Lauraine, E.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 263 - 268
  • [22] The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial
    Miyahara, Daisuke
    Ueda, Taeko
    Katsuda, Takahiro
    Maehara, Miyako
    Fukagawa, Satoshi
    Miyata, Kohei
    Nam, Sung Ouk
    Kondo, Haruhiko
    Miyamoto, Shingo
    ANTICANCER RESEARCH, 2015, 35 (08) : 4521 - 4525
  • [23] Phase III trial of transarterial chemotherapy in patients with unresectable hepatocellular carcinoma.
    Rudolph, KL
    Kubicka, S
    Chavan, A
    Kirchhoff, TD
    Layer, G
    Gallkowski, U
    Schmoll, E
    Galanski, U
    Manns, MP
    HEPATOLOGY, 1997, 26 (04) : 1857 - 1857
  • [24] Pegylated Liposomal Doxorubicin and Carboplatin in Late-relapsing Ovarian Cancer: A GINECO Group Phase II Trial
    Weber, Beatrice
    Lortholary, Alain
    Mayer, Francoise
    Bourgeois, Hugues
    Orfeuvre, Hubert
    Combe, Martin
    Platini, Christian
    Cretin, Jacques
    Fric, Daniele
    Paraiso, Desire
    Pujade-Lauraine, Eric
    ANTICANCER RESEARCH, 2009, 29 (10) : 4195 - 4200
  • [25] Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma
    Katsaros, D
    Oletti, MV
    de la Longrais, IAR
    Ferrero, A
    Celano, A
    Fracchioli, S
    Donadio, M
    Passera, R
    Cattel, L
    Bumma, C
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 300 - 306
  • [26] Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer
    Strauss, Hans-Georg
    Hemsen, Alice
    Karbe, Ina
    Lautenschlaeger, Christine
    Persing, Monika
    Thomssen, Christoph
    ANTI-CANCER DRUGS, 2008, 19 (05) : 541 - 545
  • [27] Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
    Vergote, Ignace
    Finkler, Neil J.
    Hall, James B.
    Melnyk, Ostap
    Edwards, Robert P.
    Jones, Marsha
    Keck, James G.
    Meng, Lisa
    Brown, Gail L.
    Rankin, Elaine M.
    Burke, James J.
    Boccia, Ralph V.
    Runowicz, Carolyn D.
    Rose, Peter G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 772 - 780
  • [28] Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma
    Maeda, Osamu
    Kajiyama, Hiroaki
    Shibata, Kiyosumi
    Nakamura, Shigeo
    Kikkawa, Fumitaka
    ANTICANCER RESEARCH, 2020, 40 (05) : 2497 - 2507
  • [29] A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma
    Halm, U
    Etzrodt, G
    Schiefke, I
    Schmidt, F
    Witzigmann, H
    Mössner, J
    Berr, F
    ANNALS OF ONCOLOGY, 2000, 11 (01) : 113 - 114
  • [30] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee, Keun Seok
    Ro, Jungsil
    Nam, Byung-Ho
    Lee, Eun Sook
    Kwon, Youngmee
    Kwon, Hye Soo
    Chung, Ki Wook
    Kang, Han Sung
    Kim, Eun A.
    Kim, Seok Won
    Shin, Kyung Hwan
    Kim, Seok-Ki
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 481 - 489
12345